Coloplast CEO struggling to find good acquisition candidate

Medtech company Coloplast is still searching high and low for a suitable acquisition to its skin and wound care business. The likelihood of finding something good is not that high at the moment, says the CEO.

Kristian Villumsen, CEO, Coloplast | Photo: Stine Bidstrup/ERH

Coloplast's skin and wound care business is lucrative, but is still too small to live up to its potential - though CEO Kristian Villumsen has plans to change that.

"We compare ourselves to the industry leaders, and looking at the rest of the company's portfolio, we want wound care to make more money - and generate better margins," he says.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Britt Meelby Jensen wants to rebuild trust in Ambu

After a turbulent time for Ambu under Juan Jose Gonzalez’s reign, new chief executive appointee Britt Meelby Jensen aims to rebuild the trust in the medtech firm, which has downgraded its expectations seven times over the past three years.

Outgoing Ambu CEO commends colleagues

”A true privilege,” says Juan Jose Gonzalez, describing his time as CEO at Ambu, which came to an end with Thursday’s announcement that Britt Meelby Jensen would take over the role.

Further reading

Related articles

Latest news

See all jobs